Germline Variant-based Dose Optimization
Germline Variant-Based Dose Optimization is a pharmacogenomic strategy that systematically adjusts chemotherapeutic drug dosing based on inherited genetic variants to maximize efficacy and minimize toxicity in individual patients.
2
Publications
109
Citations
40
Authors
31
Institutions
Publications per year
2017–2026
1
2
1–2 of 2
40
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 40
31
Oxford University Hospitals NHS Trust
Oxford, United Kingdom
1 h-index
1 publications
19 citations
University Medical Center Utrecht
Utrecht, The Netherlands
1 h-index
2 publications
180 citations
Haga Hospital
The Hague, Netherlands
1 h-index
1 publications
90 citations
Medisch Centrum Haaglanden
The Hague, The Netherlands
1 h-index
1 publications
90 citations
Deventer Ziekenhuis
Deventer, Netherlands
1 h-index
1 publications
90 citations
Amphia Ziekenhuis
Breda, The Netherlands
1 h-index
1 publications
90 citations
Maastricht University
Maastricht, The Netherlands
1 h-index
1 publications
90 citations

University of Amsterdam
Amsterdam, The Netherlands
1 h-index
1 publications
90 citations
1–8 of 31
1 publications · 90 citations
1
h-index
1–1